What is PEPL P/E ratio?

PepperLime Health Acquisition Corporation's P/E ratio is 57.53. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.

What is PEPL return on equity (ROE)?

PepperLime Health Acquisition Corporation's return on equity (ROE) is 1.97%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is PepperLime Health Acquisition Corporation's market cap?

PepperLime Health Acquisition Corporation has a market capitalization of $55.35M.

NASDAQ · Shell Companies

PepperLime Health Acquisition Corporation (PEPL) Stock

Q: What is PepperLime Health Acquisition Corporation (PEPL) stock price today?

PepperLime Health Acquisition Corporation (PEPL) is currently trading at $10.93, up 0.18% today.

$10.93 +0.18% NASDAQ: PEPL Financial Services

PepperLime Health Acquisition Corporation, founded in 2021 and headquartered in San Francisco, California, aims to achieve a business combination. This encompasses various strategic transactions like mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or other comparable corporate arrangements with one or more entities.

Valuation

Metric	Value
Price	$10.93
Market Cap	$55.35M
P/E Ratio	57.53
P/B Ratio	1.10
P/S Ratio	0.00
EPS (TTM)	$0.19
52-Week High	$11.00
52-Week Low	$10.18
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	1.97%
ROA	1.89%
ROCE	-0.77%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	1.78

Annual Financials (USD)

Metric	2021	2022
Revenue	$0	$0
Operating Profit	$0	$-1.0M
Net Profit	$0	$3.0M
EPS	$-0.02	$0.19
Op Margin	—	—

Balance Sheet (USD)

Metric	2021	2022
Total Assets	$174.0M	$175.0M
Total Liabilities	$6.0M	$7.0M
Cash	$1.0M	$1.0M
Borrowings	$0	$0

Latest News

CF Industries Q2 Earnings, Revenue Rise MT Newswires · Aug 5, 2026 News Corp Fiscal Q4 Adjusted Earnings, Revenue Rise MT Newswires · Aug 5, 2026 Magnite (NASDAQ:MGNI) Misses Q2 CY2026 Revenue Estimates, But Stock Soars 8.6% StockStory · Aug 5, 2026 Correction: Manulife Financial Q2 Core Earnings Rise MT Newswires · Aug 5, 2026 Magnera: Fiscal Q3 Earnings Snapshot Associated Press · Aug 5, 2026

Cash Flow (USD)

Metric	2021	2022
Operating Cash Flow	$-1.0M	$0
Investing Cash Flow	$-172.0M	$0
Financing Cash Flow	$174.0M	$0
Net Cash Flow	$1.0M	$0
Free Cash Flow	$-1.0M	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	-1.73
EV / EBITDA	-40.24
FCF Yield	-0.79%
Quick Ratio	1.78
Interest Coverage	—
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AEONAEON Biopharma, Inc.	$0.25	-11.01%	-0.08	$10.85M	0.00%
CLRCClimateRock	$12.00	+100.00%	-23.08	$55.97M	0.00%
DHAIDIH Holding US, Inc.	$0.02	+0.00%	0.00	$41853	0.00%
GMFIAetherium Acquisition Corp.	$11.04	-3.66%	126.32	$56.37M	0.00%
HHGCHHG Capital Corporation	$11.12	+0.09%	41.19	$56.16M	0.00%

About PepperLime Health Acquisition Corporation

PepperLime Health Acquisition Corporation is headquartered in US.

PepperLime Health Acquisition Corporation (PEPL) stock trades at $10.93 with a market capitalization of $55.35M. The stock is valued at a price-to-earnings (P/E) ratio of 57.53, price-to-book of 1.10, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $10.18 and $11.00, and currently trades at or near its 52-week high.

On profitability, PepperLime Health Acquisition Corporation generates a return on equity (ROE) of 1.97%, return on capital employed of -0.77%.

Official website: www.pepperlimehealth.com